The report provides a detailed analysis of the current acute respiratory distress syndrome (ARDS) marketed drugs and late-stage pipeline drugs. Inside the ARDS Market | How Tech, Awareness, Rising ...

The R/I ratio showed limited accuracy in predicting lung recruitability in ARDS but reliably identified low recruiters.

June 3, 2020 — Researchers have been investigating the downstream effects of acute respiratory distress syndrome, or ARDS, for years. As the COVID-19 pandemic rages on, their work has relevance ...

Alcohol-related lung disease (ARLD) is a potential complication of alcohol use disorder (AUD). Learn more about the signs and symptoms here.

North America acute respiratory distress syndrome (ARDS) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is ...

BioAegis’ lead product, rhu-pGSN, is currently being studied in a 600-patient global Phase 2 trial for patients with moderate to severe Acute Respiratory Distress Syndrome (ARDS).

The global acute respiratory distress syndrome (ARDS) treatment market was valued at approximately USD $$ billion in 2022 and is expected to grow at a robust CAGR of more than $% during the forecast ...